Clinical trials
Effectiveness clinical trials
Below are recruiting effectiveness clinical trials, each written for real people, not researchers. We’re tracking 6,377 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07162415Recruiting
Ganglion resection for wrist pain
This trial tests if removing a wrist ganglion (a benign fluid-filled lump) helps reduce pain better than other treatments. It is for adults with wrist pain from a confirmed ganglion cyst who have not had wrist surgery before.
HelsinkiAges 18 years+ - NCT07157345RecruitingPhase 1
Testing PDR-001 for Parkinson's Disease
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
Shanghai, Shanghai MunicipalityAges 40–65 - NCT07163247Recruiting
Pet robot help for ICU patients on a ventilator
This trial tests if spending time with a robotic pet (like a dog or cat) can help patients in the intensive care unit who are having trouble breathing on their own. It is for people who have been on a breathing machine for more than three days and whose first attempt to breathe without it didn't work.
TaipeiAges 18 years+ - NCT07157124Recruiting
Testing visual patterns to reduce alcohol cravings
This study tests whether a simple visual pattern on your computer screen can help reduce alcohol cravings and drinking. If you're a college student who drinks at least once a week and experiences cravings, you may be able to help find a new way to manage urges.
Laramie, WyomingAges 18–29 - NCT07162311Enrolling by invitation
Home brain stimulation for rheumatoid arthritis pain
This trial tests if a gentle, home-based brain stimulation device (tDCS) can reduce chronic pain in people with rheumatoid arthritis who have low inflammation. It may offer a drug-free way to manage pain.
Porto Alegre, Rio Grande do SulAges 18–70 - NCT07162285Enrolling by invitation
Bubble CPAP for Preterm Babies with Breathing Problems
This trial tests a special breathing support called bubble CPAP, given right after birth in the delivery room, to help preterm babies (born before 34 weeks) who are having trouble breathing. It aims to see if starting this treatment early can improve their breathing and health.
DhakaAges 5 minutes–30 minutes - NCT07161050Recruiting
Low nicotine and price effects on illegal cigarette buying
This study looks at how low-nicotine cigarettes and higher cigarette prices affect people's choices to buy illegal or cheaper cigarettes. It may help understand how to reduce smoking.
Roanoke, VirginiaAges 21 years+ - NCT07158216Recruiting
Long-term effects of brain stimulation in primary progressive aphasia
This study tests whether brain stimulation can help people with primary progressive aphasia (a type of dementia that mainly affects language) maintain or improve their communication skills over time. It looks at two types of stimulation: transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS).
MadridAges 18 years+ - NCT07157007RecruitingPhase 2
Testing a New COVID-19 Drug for Mild to Moderate Cases
This trial tests a new drug, ratutrelvir, for people with mild to moderate COVID-19. It aims to find a safe and effective dose to help you feel better faster.
Charlestown, New South WalesAges 18 years+ - NCT07162116RecruitingPhase 1
Effect of XY0206 on heart rhythm in healthy Chinese volunteers
This trial tests whether a new drug called XY0206 affects the heart's electrical activity (QTc interval). Healthy participants take either XY0206, a placebo, or a control drug to compare effects. It helps ensure the drug is safe for the heart before testing in patients.
Zibo, ShandongAges 18–45 - NCT07163182RecruitingPhase 1
Safety study of nasal CHF6467 in healthy volunteers
This study tests a new medicine called CHF6467 given as a nasal spray. It looks at how safe the medicine is, how it is absorbed and removed from the body, and what side effects it might cause. Healthy volunteers aged 18 to 55 can take part.
SofiaAges 18–55 - NCT06618963RecruitingPhase 4
Omalizumab for food allergy skin effects
This trial tests if omalizumab (Xolair) can improve skin reactions in people with food allergies. It may help reduce allergic symptoms triggered by foods like peanut, egg, or milk.
Denver, ColoradoAges 1–55 - NCT06955377Recruiting
Bending forward and airway protection in Parkinson's disease
This study looks at how bending forward (trunk flexion) affects your body's ability to protect your airway in Parkinson's disease. It may help understand breathing risks and guide therapy.
PragueAges 18 years+ - NCT06867926Recruiting
Heart rehab and its effect on DNA and inflammation
This study looks at whether a cardiac rehabilitation program can reduce DNA damage and inflammation in people with coronary artery disease. It may help patients understand how exercise and lifestyle changes can affect their heart health at a cellular level.
KayseriAges 18–65 - NCT06955052Recruiting
Maze activity for balance and walking in Down syndrome
This study tests a fun activity program called 'Minds In Motion The Maze' to see if it helps improve balance and walking in children with Down syndrome.
Lahore, Punjab ProvinceAges 8–12 - NCT06805786Recruiting
Switching from scanned to real-time CGM for type 2 diabetes
This study tests whether switching from a FreeStyle Libre 2 (which you scan to check sugar) to a Dexcom G7 (which sends sugar readings automatically to your phone) can improve blood sugar control in adults with type 2 diabetes who use insulin.
Toronto, OntarioAges 18 years+ - NCT06837103Recruiting
Continuous glucose monitor and coaching for type 2 diabetes
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
Toronto, OntarioAges 18 years+ - NCT06957288Recruiting
Mindfulness program for nurses dealing with death
This study tests if a mindfulness-based education program can help nurses who work in high-stress areas like emergency rooms, intensive care units, and palliative care feel less anxious about death and more comfortable with their own awareness of it.
Kastamonu, CentralAges 18 years+ - NCT06956365Recruiting
Comparing two medicines for bleeding during c-section under general anesthesia
This trial compares two drugs, oxytocin and carbetocin, to see which one better controls blood pressure and heart rate changes during cesarean section surgery. Both medicines help the uterus contract after delivery to reduce bleeding.
Van, TuşbaAges 18–40 - NCT06956222Recruiting
Home vs in-person rehab for knee osteoarthritis
This study compares doing physical therapy exercises at home through a video call (tele-rehab) versus doing them in person at a clinic. It is for people with mild to moderate knee osteoarthritis to see if home rehab works just as well.
JeddahAges 40–80 - NCT07147231RecruitingPhase 1/Phase 2
Pidnarulex plus cemiplimab for MSS colorectal cancer
This trial tests two drugs together: pidnarulex (a targeted therapy) and cemiplimab (an immunotherapy that helps your immune system fight cancer). It is for people with advanced colorectal cancer that is microsatellite stable (MSS) and has not responded to current treatments, especially if their tumor has a MYC or FBXW7 change.
Aurora, ColoradoAges 18 years+ - NCT07150702Recruiting
Close follow-up for low back pain
This study is testing whether closer follow-up care helps people with long-term low back pain feel better faster. You'll receive a standard physical therapy program but with more frequent check-ins to see if extra support improves your recovery.
Istanbul, FatihAges 18–65 - NCT07147062Recruiting
Pain relief after hernia surgery in children
This trial compares two types of pain blocks (rectus sheath block or caudal epidural block) used in children having a specific hernia surgery. It aims to see which block works better for controlling pain after the procedure.
Altındağ, AnkaraAges 1–8 - NCT07146906RecruitingPhase 2
Study of zigakibart for IgA nephropathy
This trial tests a new drug called zigakibart for people with IgA nephropathy, a kidney disease. It aims to see if the drug can help reduce protein in the urine and protect kidney function.
Denver, ColoradoAges 18–100
Hear when a new Effectiveness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for effectiveness?
- Yes. Clin2 currently lists 6,377 recruiting effectiveness studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a effectiveness trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a effectiveness trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.